课题基金 / 基金详情

Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease

Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease
SARS-CoV-2 3CL 蛋白酶潜在抑制剂的增强发现
批准号:
422705
负责人:
Cherkasov Artem
金额:
$72.78万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-02-01 至 2022-02-01
关键词:

项目摘要

项目成果

Cherkasov Artem的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The COVID-19 epidemic is causing serious or even fatal respiratory tract infections around the city of Wuhan, China and other countries. The urgent situation is pressing the global community to respond rapidly together to develop a vaccine or small molecu
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
  • 批准号:
    429444
  • 项目类别:
    Operating Grants
  • 资助金额:
    $153.65万
  • 财政年份:
    2020
  • 负责人:
    Cherkasov Artem
  • 依托单位:
Sex as a Biological Variable Supplement - Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease
  • 批准号:
    424703
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Cherkasov Artem
  • 依托单位:
海外基金